CRISPR Therapeutics AG

SEC 4 · Filed

0001193125-26-264382Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jun 5, 2026

Grant, award or other acquisition by Behbahani Ali

Security
Stock Option (Right to Buy)
Code
A
Shares
13,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-06-05",
  "direction": "A",
  "exercise_price": "51.84",
  "expiration": "2036-06-05",
  "footnotes": {
    "F1": "Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on June 30, 2026 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2027 Annual Meeting."
  },
  "owners": [
    {
      "cik": "0001613867",
      "name": "Behbahani Ali",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "13000",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "false",
  "security": "Stock Option (Right to Buy)",
  "shares": "13000",
  "table": "II",
  "underlying_security": "Common Shares",
  "underlying_shares": "13000"
}